Defence Minister Rajnath Singh launched the first batch of over 10,000 doses of anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) on Monday. The medicine that comes in powder form must be taken orally by dissolving it in water. 2-DG is expected to help India in its fight against the present COVID situation.
The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. On May 1, the Drugs Controller General of India (DCGI) approved the emergency use of the drug on patients with moderate to severe symptoms.
Clinical trials of the medicine have proved that the drug helps in the faster recovery of COVID-19 patients and reduces supplemental oxygen dependence.